Cargando…
Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis
We describe two cases of SGLT2i-induced euglycaemic diabetic ketoacidosis, which took longer than we anticipated to treat despite initiation of our DKA protocol. Both patients had an unequivocal diagnosis of type 2 diabetes, had poor glycaemic control with a history of metformin intolerance and pres...
Autores principales: | Rafey, Mohammed Faraz, Butt, Arslan, Coffey, Barry, Reddington, Lisa, Devitt, Aiden, Lappin, David, Finucane, Francis M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765316/ https://www.ncbi.nlm.nih.gov/pubmed/31600728 http://dx.doi.org/10.1530/EDM-19-0087 |
Ejemplares similares
-
Diabetic ketoacidosis after the treatment of anaphylaxis
por: Brenner, Daniel S, et al.
Publicado: (2022) -
Diabetic ketoacidosis following PEG-asparaginase therapy
por: Ahmad, Miriam Hinaa, et al.
Publicado: (2018) -
Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism
por: Patel, Shivani, et al.
Publicado: (2019) -
Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis
por: Tzoulis, Ploutarchos, et al.
Publicado: (2018) -
Presentation of new onset type 1 diabetes with diabetic ketoacidosis and hyperosmolar hyperglycaemia after a single dose of nivolumab and ipilimumab
por: Stathi, Dimitra, et al.
Publicado: (2023)